Candida albicans infection enhances immuno suppression induced by cyclophosphamide by selective priming of suppressive myeloid progenitors for NO production

被引:20
作者
Angulo, I
Jiménez-Díaz, MB
García-Bustos, JF
Gargallo, D
de las Heras, FG
Muñoz-Fernández, MA
Fresno, M [1 ]
机构
[1] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain
[2] GlaxoSmithKline DDW, Tres Cantos, Spain
[3] Hosp Gregorio Maranon, Dept Immunol, Madrid, Spain
关键词
D O I
10.1016/S0008-8749(02)00521-X
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Systemic infections caused by fungi after cytoreductive therapies are especially difficult to deal with in spite of currently available antimicrobials. However, little is known about the effects of fungi on the immune system of immunosuppressed hosts. We have addressed this by studying the in vitro T cell responses after systemic infection with Candida albicans in cyclophosphamide-treated mice. After cyclophosphamide treatment, a massive splenic colonization of the spleens, but not lymph nodes, by immature myeloid progenitor (Ly-6G(+)CD11b(+)) cells is observed. These cells are able to suppress proliferation of T lymphocytes via a nitric oxide (NO)-dependent mechanism. Systemic infection with a sublethal dose of C albicans did not cause immunosuppression per se but strongly increased NO-dependent suppression in cyclophosphamide-treated mice, by selective priming of suppressive myeloid progenitors (Ly-6G(+)CD11b(+)CD31(+)CD40(+)WGA(+)CD117(low/-)CD34(low/-)) for iNOS protein expression. The results indicate that systemic C albicans infection can augment the effects of immunosuppressive therapies by promoting functional changes in immunosuppressive cells. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:46 / 58
页数:13
相关论文
共 56 条
[31]   Immune suppression by recombinant interleukin (rIL)-12 involves interferon γ induction of nitric oxide synthase 2 (iNOS) activity:: Inhibitors of NO generation reveal the extent of rIL-12 vaccine adjuvant effect [J].
Koblish, HK ;
Hunter, CA ;
Wysocka, M ;
Trinchieri, G ;
Lee, WMF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (09) :1603-1610
[32]  
KREMERY V, 1996, J HOSP INFECT, V33, P109
[33]  
Lasarte JJ, 1999, J IMMUNOL, V162, P5270
[34]   REGULATION OF LYMPHOCYTE FUNCTIONS BY NITRIC-OXIDE [J].
LIEW, FY .
CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (03) :396-399
[35]   Antifungal prophylaxis during neutropenia and immunodeficiency [J].
Lortholary, O ;
Dupont, B .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (03) :477-+
[36]   In vivo blockage of nitric oxide with aminoguanidine inhibits immunosuppression induced by an attenuated strain of Salmonella typhimurium, potentiates Salmonella infection, and inhibits macrophage and polymorphonuclear leukocyte influx into the spleen [J].
MacFarlane, AS ;
Schwacha, MG ;
Eisenstein, TK .
INFECTION AND IMMUNITY, 1999, 67 (02) :891-898
[37]   NITRIC-OXIDE SUPPRESSION OF HUMAN HEMATOPOIESIS IN-VITRO - CONTRIBUTION TO INHIBITORY-ACTION OF INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA [J].
MACIEJEWSKI, JP ;
SELLERI, C ;
SATO, T ;
CHO, HJ ;
KEEFER, LK ;
NATHAN, CF ;
YOUNG, NS .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (02) :1085-1092
[38]   Nitric oxide and macrophage function [J].
MacMicking, J ;
Xie, QW ;
Nathan, C .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :323-350
[39]  
Medot-Pirenne M, 1999, J IMMUNOL, V163, P5877
[40]   CONTROL OF GRANULOCYTES AND MACROPHAGES - MOLECULAR, CELLULAR, AND CLINICAL ASPECTS [J].
METCALF, D .
SCIENCE, 1991, 254 (5031) :529-533